Published on in Vol 4, No 2 (2021): Jul-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/27869, first published .
Trends in Hidradenitis Suppurativa Disease Severity and Quality of Life Outcome Measures: Scoping Review

Trends in Hidradenitis Suppurativa Disease Severity and Quality of Life Outcome Measures: Scoping Review

Trends in Hidradenitis Suppurativa Disease Severity and Quality of Life Outcome Measures: Scoping Review

Journals

  1. Mora Hurtado A, Endo J. Lack of skin of color reporting in disease severity rating tools used for inflammatory skin conditions: A scoping review. Journal of the American Academy of Dermatology 2024;90(2):432 View
  2. Pathak G, Chandy R, Naini V, Feldman S, Rao B, Vassileva S. Quality of Life Assessments Utilized in Vitiligo Clinical Trials. Dermatologic Therapy 2023;2023(1) View
  3. Eshmawi M, Yousef Al-Mudaiheem H, Fatani M, Binamer Y, Alajlan M, Alharithy R, Alotaibi H, Almohanna H, Alsantali A, Madani A, Al-Faraidy N, Bechara F, H. Al-Jedai A. Expert consensus on unmet needs, referral criteria and treatment goals for hidradenitis suppurativa in Saudi Arabia. Journal of Dermatological Treatment 2024;35(1) View
  4. Pathak G, Patel K, Wachuku C, Truong T, Agarwal P, Rao B. Trends in disease severity and quality of life outcome measures in pemphigus clinical trials: A scoping review. Skin Health and Disease 2024;4(5) View
  5. De D, Baskaran N, Thakur V, Hanumanthu V, Bakshi S, Bhandari S, Katoch D, Handa S. A Clinicodemographic Study of Indian Patients with Hidradenitis Suppurativa and its Association with Metabolic Syndrome. Indian Dermatology Online Journal 2024 View
  6. Park S, Hsiao J, Aleshin M. Innovations in Hidradenitis Suppurativa. Dermatologic Clinics 2025;43(1):35 View